Drug interactions
Metformin-sitagliptin + Ponatinib
Severity: Minor
Metformin-sitagliptin and Ponatinib: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Ponatinib may inhibit P-glycoprotein and raise sitagliptin concentrations. The clinical consequence is likely small given the wide therapeutic margin of sitagliptin.
What this interaction means in plain words
Metformin-sitagliptin and Ponatinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Metformin-sitagliptin belongs to Endocrine; Ponatinib belongs to Oncology.
Why it happens
P-glycoprotein inhibition may reduce sitagliptin efflux and increase exposure.
What to do
No dose change is usually needed. Monitor for glucose changes and adverse effects.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Metformin-sitagliptin and Ponatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Metformin-sitagliptin
Other interactions of Ponatinib
Frequently asked questions
Can I take Metformin-sitagliptin with Ponatinib?
MediHelp rates the interaction as minor. Metformin-sitagliptin and Ponatinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Ponatinib may inhibit P-glycoprotein and raise sitagliptin concentrations. The clinical consequence is likely small given the wide therapeutic margin of sitagliptin.
How serious is the interaction between Metformin-sitagliptin and Ponatinib?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change is usually needed. Monitor for glucose changes and adverse effects.
What other medicines interact with Metformin-sitagliptin?
MediHelp also lists interactions of Metformin-sitagliptin with, for example, Clozapine, Contrast media, Diatrizoate meglumine / diatrizoate. The full list is on the Metformin-sitagliptin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
